✦ LIBER ✦

Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse

✍ Scribed by Twentyman, P R

Book ID: 109835493
Publisher: Nature Publishing Group
Year: 1983
Tongue: English
Weight: 779 KB
Volume: 47
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1983.7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modification of the radiation response o

Modification of the radiation response of the mouse kidney by misonidazole and WR-2721

✍ M.V. Williams; J. Denekamp 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 712 KB

In vitro studies on the absorption of WR

In vitro studies on the absorption of WR-2721 by tumors and normal tissues

✍ Mark A. Ritter; Darrell Q. Brown; Donna J. Glover; John M. Yuhas 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 466 KB

The effect of misonidazole combined with

The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan

✍ McNally, N J 📂 Article 📅 1982 🏛 Nature Publishing Group 🌐 English ⚖ 555 KB

Modification of the radiation response o

Modification of the radiation response of normal tissue by vitamin C and by zinc deficiency

✍ J.L. Redpath; M.J. Renan; M. Colman 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 162 KB

The effect of s-2-(3-aminopropylamino)-e

The effect of s-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721) on the toxicity of melphalan on normal and tumor tissue in mice

✍ E.A. Wist; T.J. McElwain; J.L. Millar 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Modification of blood flow in the HSN tu

Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ETB receptor agonist, IRL 1620

✍ Katrina M. Bell; David J. Chaplin; Beverley A. Poole; Vivien E. Prise; Gillian M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 208 KB 👁 2 views

Activation of endothelin receptors on the vasculature can produce a variety of responses from potent vasoconstriction to mild vasodilation, depending on the receptor complement within the tissue. To elucidate the potential role of endothelin analogues as tumour blood flow modifiers, we have evaluate